ArticleCase reports in oncology

Long-Term Control after Intermittent Reintroduction of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Case Report.

Kenta Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.